PMS31 THE IMPACT OF CHANGES IN ADALIMUMAB, ETANERCEPT, AND INFLIXIMAB DOSES ON THE COSTS OF TREATING RHEUMATOID ARTHRITIS
Nov 1, 2010, 00:00 AM
10.1016/S1098-3015(11)72184-2
https://www.valueinhealthjournal.com/article/S1098-3015(11)72184-2/fulltext
Section Title :
RESEARCH POSTER ABSTRACTS
Section Order :
347
First Page :
A308
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72184-2&doi=10.1016/S1098-3015(11)72184-2